Barclays analyst Steven Valiquette maintained a Hold rating on Universal Health (UHS) yesterday and set a price target of $136. The company’s shares closed yesterday at $138.83, close to its 52-week high of $141.41.
According to TipRanks.com, Valiquette is a 3-star analyst with an average return of 2.5% and a 48.5% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Patterson Companies Inc, and WellCare Health Plans.
The word on The Street in general, suggests a Hold analyst consensus rating for Universal Health with a $141 average price target, representing a 1.6% upside. In a report released today, Piper Jaffray also maintained a Hold rating on the stock with a $149 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $141.41 and a one-year low of $109.37. Currently, Universal Health has an average volume of 797.7K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Universal Health Services, Inc. operates as a healthcare management company, which through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. It operates through the Acute Care Hospital Services, Behavioral Health Care Services, and Other.
